Results 51 to 60 of about 1,113 (191)
Clinical Ophthalmology, 2020 Alfredo Adán,1 Francisco Cabrera,2 Marta S Figueroa,3 Enrique Cervera,4 Francisco J Ascaso,5 Patricia Udaondo,6 Maximino Abraldes,7 Miguel Ángel Reyes,8 Marta Pazos,1 Bernardete Pessoa,9 Félix Armadá10 1Hospital Clínic ...
Adán A +10 more
doaj
ILUVIEN® Intravitreales Implantat bei diabetischem Makulaödem – Erste Fallstudien
European Ophthalmic Review, 2013 Das diabetische Makulaödem (DMÖ) ist eine wesentliche Ursache für den Verlust der Sehkraft, und die Herausforderungen in der Behandlung dieser progressiven Erkrankung bestehen weiter fort. Kortikosteroide bieten einen umfassenden Behandlungsansatz, indem sie die Konzentration inflammatorischer Zytokine und von Wachstumsfaktoren, wie z. B.
Anke Messerschmidt-Roth +1 more
openaire +1 more source
Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
Journal of Ophthalmology, Volume 2018, Issue 1, 2018., 2018 Diabetic retinopathy (DR) is classically defined by its vascular lesions and damage in the neurons of the retina. The cellular and clinical elements of DR have many features of chronic inflammation. Understanding the individual cell‐specific inflammatory changes in the retina may lead to novel therapeutic approaches to prevent vision loss.
Lei Lu +4 more
wiley +1 more source
Imaging, quantitation and kinetic modelling of intravitreal nanomaterials [PDF]
, 2022 In this study, the intravitreal pharmacokinetics of nanomaterials were investigated in vivo in rats and rabbits. Impact of particle size and shape (spherical, longitudinal) on ocular particle distribution and elimination was investigated with fundus ...
Cao, Shoupeng +10 more
core +2 more sources
Iluvien® in der Therapie des strahleninduzierten Makulaödems
, 2019 27. Jahrestagung der Regionalgesellschaft der Augenärzte Sachsen-Anhalts und Thüringens e. V.
Zimmermann, L +3 more
openaire +2 more sources
The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy
Oxidative Medicine and Cellular Longevity, Volume 2018, Issue 1, 2018., 2018 Diabetic retinopathy is one of the most serious microvascular complications induced by hyperglycemia via five major pathways, including polyol, hexosamine, protein kinase C, and angiotensin II pathways and the accumulation of advanced glycation end products.
Meng-Yu Wu +4 more
wiley +1 more source
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management [PDF]
, 2016 INTRODUCTION: With the increasing use of intravitreal administration of corticosteroids in macular edema, steroid-induced intraocular pressure (IOP) rise is becoming an emergent issue.
Denis, P +7 more
core
Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management [PDF]
, 2020 Purpose: To investigate baseline characteristics of patients undergoing additional antivascular endothelial growth factor (VEGF) injections for residual or recurrent diabetic macular edema (DME) in the first year after 0.19-mg fluocinolone acetonide (FAc)
Bandello F. +5 more
core +1 more source
BMEMat, Volume 4, Issue 1, March 2026.Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen +7 more
wiley +1 more source
Ocular Complications of Diabetes and Therapeutic Approaches
BioMed Research International, Volume 2016, Issue 1, 2016., 2016 Diabetes mellitus (DM) is a metabolic disease defined by elevated blood glucose (BG). DM is a global epidemic and the prevalence is anticipated to continue to increase. The ocular complications of DM negatively impact the quality of life and carry an extremely high economic burden.
Victoria J. Vieira-Potter +3 more
wiley +1 more source